Interleukin-1 expression by neutrophils in rheumatoid arthritis.
AUTOR(ES)
Quayle, J A
RESUMO
OBJECTIVE--To determine if neutrophils from blood and synovial fluid of patients with rheumatoid arthritis and other joint arthropathies express interleukin-1 beta mRNA. METHODS--RNA was isolated from neutrophils from patient and control blood, and synovial fluid of patients, probed in northern blots, and quantified by densitometry. It was also isolated and analysed from control blood neutrophils after incubation in vitro with granulocyte macrophage colony stimulating factor (GM-CSF). RESULTS--Neutrophils from the synovial fluid of patients with rheumatoid arthritis contained low levels of mRNA for interleukin-1 beta--between 0.1 and 2% of those observed during stimulation of control neutrophils with GM-CSF for one hour. Higher levels (4-40% of the maximal GM-CSF values) were observed in blood neutrophils from patients with rheumatoid arthritis. CONCLUSIONS--Neutrophils contribute to the cytokine network in rheumatoid arthritis. In some circumstances, activation of transcription may occur within the circulation of these patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1010046Documentos Relacionados
- Calcitonin inhibits production of immunoglobulins, rheumatoid factor and interleukin-1 by mononuclear cells from patients with rheumatoid arthritis.
- Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis.
- Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis.
- Enhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis.
- Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.